Faeth Therapeutics, Inc FTH
$40.05 $1.05 (2.69%) 1D
Last Updated: Sep 04, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Faeth Therapeutics, Inc Stock Halal?
Shariah Compliance Analysis of FTH Stock
United States Health Care Small Cap No. As of September 2026, Faeth Therapeutics, Inc (FTH) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Faeth Therapeutics, Inc does not pass Musaffa's business and financial screening criteria.
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company is headquartered in Austin, Texas and currently employs 29 full-time employees. The company went IPO on 2021-02-04. The firm's lead program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer. PIKTOR engages three nodes simultaneously: PI3K-alpha upstream, mTORC1 and mTORC2 downstream, simultaneously. PIKTOR is designed to deliver multi-node pathway inhibition in an oral formulation. Its pipelines include PIKTOR (PIK-201), PIKTOR (PIK-101) and Sapanisertib.
FTH Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Faeth Therapeutics, Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Faeth Therapeutics, Inc (FTH) Chart
Financial Metrics & Statements of Faeth Therapeutics, Inc (FTH)
FAQ's for Faeth Therapeutics, Inc (FTH)
- As of September 2026, Faeth Therapeutics, Inc FTH is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Faeth Therapeutics, Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Faeth Therapeutics, Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Faeth Therapeutics, Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Faeth Therapeutics, Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Faeth Therapeutics, Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Faeth Therapeutics, Inc (FTH)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
